Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

[Summary] 专注于肿瘤和糖尿病一类新药的研发和生产。

首药控股(北京)股份有限公司成立于2016年4月19日,是由市、区两级国有资金参股的混合所有制高新技术企业。公司总部位于北京亦庄经济技术开发区景园街,专注于具有自主知识产权的创新药的研发和生产。 公司奉行绩效原则,注重经验和品格,在创新药方面将不可能成为了可能。首药控股目前已于全球范围内获发明专利授权逾百项,获得国家一类新药临床批件17个(包括合作研发项目),荣获国家“十二五”“十三五”重大新药创制专项8项。目前,已有2个新药进入临床III期、2个新药进入临床II期、12个新药进入临床I期。 创好药、造中国患者能够用得起的一类新药,是首药控股人的追求。让我们在“责、权、利”清晰又扛得住的机制里,撸起袖子加油干,把首药控股锻造成为集研发、生产、销售于一体的国际化药企。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

首药控股 Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal: 上交所

首药控股 Recruitment Overview / Current Status (31 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 35%
  • 2024: Up 44%
  • 2023: Down 28%
  • 2022: Up 43%
首药控股 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
首药控股 Campus Recruitment & Advanced Degree Talent Demand
Master's 5 Doctorate 11
Note: How fast is hiring at 首药控股(北京)股份有限公司 growing? 首药控股2025年40个(下降35%),2024年62个(增长44%),2023年43个(下降28%),2022年60个(增长43%),2021年42个. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

首药控股 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 7%
  • 2024: Up 56%
  • 2023: Down 47%
  • 2022: Up 89%
首药控股 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 首药控股(北京)股份有限公司 growing? 首药控股历年硕士招聘职位量:2025年13个(下降7%),2024年14个(增长56%),2023年9个(下降47%),2022年17个(增长89%),2021年9个.

首药控股 Doctoral Degree Job Demand Analysis

(More)
+14%
Growth Rate
2026 vs 2025
  • 2025: Up 100%
  • 2024: Up 17%
  • 2023: Down 40%
  • 2022: Up 100%
首药控股 Doctoral Hiring by Year: 2026 — 2 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 首药控股(北京)股份有限公司 growing? 首药控股历年博士招聘职位量:2026年16个(增长14%),2025年14个(增长100%),2024年7个(增长17%),2023年6个(下降40%),2022年10个(增长100%),2021年5个. 首药控股在北京博士人才需求中排名第44, 首药控股博士工资大部分在30-50K以上.

首药控股 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 首药控股(北京)股份有限公司? Based on an analysis of 首药控股's job postings over the past year, “生物/制药/化工/环保类”需求占37.5%,“医疗卫生/美容保健类”占36.1%,“其他(研发和技术类)”占27.8%,“科研类”占18.1%,“计算机/网络/技术类”占6.9%,“美术/设计/创意类”占4.2%. For reference only.

首药控股 — What Are the Salaries Like? (72 records)

Manage
salary range: 6K - 50K, 57% of roles pay ¥30-50K以上
Note: salary statistics are based on 72 salary records from the past year and depend on the job sample. For reference only.
首药控股(北京)股份有限公司工资待遇怎么样?首药控股57%的岗位拿30-50K以上,应届生工资¥7.0K。北京地区工资排名前45%,与同行业比+77%,经营管理类平均工资¥42.6K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 首药控股

(More)
Are salaries high at 首药控股(北京)股份有限公司? We provide: 研究员,副总,研发人员,销售,高级经理,cad,临床,毒理总监,设计总,车间,分析,化学,合规,地区经理,工人,开发经理,招聘经理,操作工,研究助理,药物制剂. Click to view detailed salary analysis by job.

首药控股 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

首药控股 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 经营管理类
    51.9% of total 51.9%
  • 生物/制药/化工/环保类
    41.6% of total 41.6%
  • 医疗卫生/美容保健类
    36.4% of total 36.4%
  • 其他(研发和技术类)
    29.9% of total 29.9%

Education

  • 本科
    44.2% of total 44.2%
  • 博士
    32.5% of total 32.5%
  • 硕士
    18.2% of total 18.2%
  • 大专
    5.2% of total 5.2%

Experience

  • 5-10年
    44.2% of total 44.2%
  • 不限
    26% of total 26%
  • 3-5年
    15.6% of total 15.6%
  • 1-3年
    13% of total 13%
View Detailed Analysis

What does 首药控股(北京)股份有限公司 require? Who is 首药控股 hiring? 首药控股招聘类别经营管理类占比最多占51.9%,其次是生物/制药/化工/环保类占41.6%。首药控股什么学历能进?本科占比最多占44.2%,其次是博士占32.5%。首药控股学历要求高吗?博士占32.5%,硕士占18.2%。工作经验首药控股有什么要求?5-10年占比最多占44.2%,其次是不限占26%。首药控股工作地区在哪?北京占比最多占96.1%,其次是成都占2.6%。 Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 14,871.9343万(元)
Legal Representative: 李文军
Date Established:
Credit Code: 91110108MA004WFJ71
Registered Address: 北京市北京经济技术开发区荣华中路10号1幢19层1单元2202-2号

Partners & Suppliers

合作开展新药研发 Source
供应商 高校/研究院
联合开展新药研发项目 Source
供应商 高校/研究院
开展临床试验合作 Source
供应商 临床试验机构
开展抗肿瘤药物临床试验 Source
供应商 临床试验机构
提供临床前研究和安全性评价服务 Source
供应商 临床前CRO

People who follow 首药控股 also follow

首药控股 Competitors (Similar Companies)

制药/药业 医药 制药 医药工业
医药 药物研发 大健康 制药
“一家拥有70余年辉煌历史的制药企业”
“大型医药流通企业”
“炮制虽繁必不敢省人工;品味虽贵必不敢减物力”
“不断创新为患者带来能显着改善其健康的药物”
医药 生物制品 生物医药 生物制药
“临床和临床前大分子生物分析一站式服务”
“药品、医疗器械研发与生产全流程“一站式”外包服务”
“抗肿瘤药和手术用药的研究和生产”
“关爱生命、嗬护健康”
“追求全民健康”
制药/药业 生物医药 制药 中成药
生物科技/生物工程 生物科技 干细胞 再生医学
“致力于研究、开发、生产及商业化全球病人可负担的创新抗体新药”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

居民维修
客服
由百度提供